Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg

Yelda Buyru Özkurt, Tomris Sengor, Tufan Evciman, Melih Haboglu, Gökçen Bas, Sevda AydinFatih Sultan Mehmet Training and Research Hospital, Istanbul, TurkeyPurpose: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% la...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yelda Buyru Özkurt, Tomris Sengor, Tufan Evciman, Melih Haboglu, Gökçen Bas, Sevda Aydin
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/bd1a0a5a7cc54e198ccc3a57d8cd6fb5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd1a0a5a7cc54e198ccc3a57d8cd6fb5
record_format dspace
spelling oai:doaj.org-article:bd1a0a5a7cc54e198ccc3a57d8cd6fb52021-12-02T06:09:43ZAdministration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg1177-54671177-5483https://doaj.org/article/bd1a0a5a7cc54e198ccc3a57d8cd6fb52009-05-01T00:00:00Zhttp://www.dovepress.com/administration-of-the-fixed-combination-of-latanoprost-0005-and-timolo-a3103https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Yelda Buyru Özkurt, Tomris Sengor, Tufan Evciman, Melih Haboglu, Gökçen Bas, Sevda AydinFatih Sultan Mehmet Training and Research Hospital, Istanbul, TurkeyPurpose: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher.Design: Prospective, randomized clinical trial.Participants: Twenty-eight patients.Methods: Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient.Results: Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment.Conclusion: A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg.Keywords: latanoprost, timolol, combination, glaucoma, intraocular pressure  Yelda Buyru ÖzkurtTomris SengorTufan EvcimanMelih HabogluGökçen BasSevda AydinDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 337-339 (2009)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Yelda Buyru Özkurt
Tomris Sengor
Tufan Evciman
Melih Haboglu
Gökçen Bas
Sevda Aydin
Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
description Yelda Buyru Özkurt, Tomris Sengor, Tufan Evciman, Melih Haboglu, Gökçen Bas, Sevda AydinFatih Sultan Mehmet Training and Research Hospital, Istanbul, TurkeyPurpose: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher.Design: Prospective, randomized clinical trial.Participants: Twenty-eight patients.Methods: Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient.Results: Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment.Conclusion: A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg.Keywords: latanoprost, timolol, combination, glaucoma, intraocular pressure 
format article
author Yelda Buyru Özkurt
Tomris Sengor
Tufan Evciman
Melih Haboglu
Gökçen Bas
Sevda Aydin
author_facet Yelda Buyru Özkurt
Tomris Sengor
Tufan Evciman
Melih Haboglu
Gökçen Bas
Sevda Aydin
author_sort Yelda Buyru Özkurt
title Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_short Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_full Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_fullStr Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_full_unstemmed Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_sort administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmhg
publisher Dove Medical Press
publishDate 2009
url https://doaj.org/article/bd1a0a5a7cc54e198ccc3a57d8cd6fb5
work_keys_str_mv AT yeldabuyruampoumlzkurt administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT tomrissengor administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT tufanevciman administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT melihhaboglu administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT gampoumlkampccedilenbas administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT sevdaaydin administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
_version_ 1718400073633628160